1,580 results on '"BRONCHIOLITIS obliterans syndrome"'
Search Results
2. Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
3. Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
4. Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
5. Glasdegib for Chronic Graft-Versus-Host Disease
6. Managed Access Programs for INC424, Ruxolitinib
7. A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
8. Ruxolitinib Vs Prednisone As First-line Therapy for CGVHD Needing Systemic Therapy
9. Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
10. A Long-term Extension Study of PCI-32765 (Ibrutinib) (CAN3001)
11. Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy
12. A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. (ROCKnrol-1)
13. Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease (THRIVE)
14. Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
15. Horizons Chronic Graft-Versus-Host-Disease Study
16. A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
17. Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)
18. Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
19. Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant
20. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease
21. A Phase 2 Study to Evaluate Vimseltinib in Adults with Active Chronic Graft-Versus-Host Disease (cGVHD)
22. Ruxolitinib Plus Fostamatinib for Steroid Refractory CGvHD
23. Hp129 Xenon Imaging and BOS in Lung Transplantation
24. A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib
25. Leflunomide in Treating Patients with Steroid Dependent Chronic Graft Versus Host Disease
26. Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
27. Improving Outcomes Assessment in Chronic GVHD
28. A Study of Photobiomodulation (PBM) Therapy in People with Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
29. A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) (AGAVE-201)
30. Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
31. A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
32. Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
33. Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
34. Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
35. Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
36. BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
37. Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
38. Expanded Access Program for Axatilimab in Chronic Graft Versus Host Disease (GVHD)
39. TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))
40. A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
41. Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease (cGVHDTele-PC)
42. Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) (BOSTON-2)
43. Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
44. Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) (BOSTON-1)
45. Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease
46. Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
47. A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation
48. Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans (ALLOPIV)
49. Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts (ECP)
50. Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.